The European Medicines Agency (EMA) has recommended granting marketing authorization for the pneumococcal vaccine Capvaxive (pneumococcal polysaccharide conjugate vaccine [21-valent]) intended to ...
Pregnant patients in their third trimester and postpartum women showed higher risk for IPD compared with nonpregnant patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback